Join
Live feed
·
PRReleasevia Quantisnow
IceCure Medical Ltd. logo

U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer

ByQuantisnow·Wall Street's wire, on your screen.
ICCM· IceCure Medical Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ICCM (IceCure Medical Ltd.) and more on Quantisnow.